Functionally distinct gene classes as bigger or smaller transcription factor traps: A possible stochastic component to sequential gene expression programs in cancer

Gene

Volumn 536, Issue 2, 2014, Pages 398-406

  Mauro, James A ^a   Blanck, George ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Apoptosis; Cell proliferation; ENCODE; Gene size; Open chromatin regions; Transcription factors

Indexed keywords

INTERFERON REGULATORY FACTOR 1; PROTEIN P53; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL CYCLE ARREST; CHROMATIN; CONTROLLED STUDY; DATA MINING; GENE EXPRESSION; GENE FUNCTION; HUMAN; NEOPLASM; PHENOTYPE; PRIORITY JOURNAL; STOCHASTIC MODEL; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL PROLIFERATION; CIITA; CLASS II TRANSACTIVATOR; ENCODE; GENE SIZE; HS; HYPERSENSITIVE; INTERFERON REGULATORY FACTOR-1; IRF-1; MAJOR HISTOCOMPATIBILITY; MHC; NFAT; NUCLEAR FACTOR, ACTIVATED TRANSCRIPTION; OPEN CHROMATIN REGIONS; SAHA; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; STAT; SUBERANILOHYDROXAMIC ACID; TF; TFBS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BINDING SITE; TRANSCRIPTION FACTORS; YING-YANG 1; YY1;

APOPTOSIS; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; INTERFERON REGULATORY FACTOR-1; K562 CELLS; NEOPLASMS; PROTEIN BINDING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84892440695     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.11.013     Document Type: Article

References (21)

1. Adams P.D., Kaelin W.G. The cellular effects of E2F overexpression. Curr. Top. Microbiol. Immunol. 1996, 208:79-93. (PubMed PMID: 8575214).
2. Ashe H.L., Briscoe J. The interpretation of morphogen gradients. Development 2006, 133(3):385-394. (PubMed PMID: 16410409). 10.1242/dev.02238.
3. Bandara L.R., Buck V.M., Zamanian M., Johnston L.H., La Thangue N.B. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 1993, 12(11):4317-4324. (PubMed PMID: 8223441; PubMed Central PMCID: PMC413728).
4. Brady H.J., Bax Gil-Gomez G. The pro-apoptotic Bcl-2 family member, Bax. Int. J. Biochem. Cell Biol. 1998, 30(6):647-650. (PubMed PMID: 9695020).
5. Eason D.D., Blanck G. High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway. J. Immunol. 2001, 166(2):1041-1048. (PubMed PMID: 11145683).
6. ENCODE Project Consortium, Myers R.M., Stamatoyannopoulos J., Snyder M., Dunham I., Hardison R.C., Bernstein B.E., Gingeras T.R., Kent W.J., Birney E., et al. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 2011 Apr, 9(4):e1001046. Epub 2011 Apr 19. (PMID:21526222; PMCID: PMC3079585).
7. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61(5):759-767. (PubMed PMID: 2188735).
8. Gartel A.L., Serfas M.S., Tyner A.L. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 1996, 213(2):138-149. (PubMed PMID: 8931660).
9. Grimm O., Coppey M., Wieschaus E. Modelling the Bicoid gradient. Development 2010, 137(14):2253-2264. (PubMed PMID: 20570935; PubMed Central PMCID: PMC2889599). 10.1242/dev.032409.
10. Jain J., Loh C., Rao A. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 1995, 7(3):333-342. (PubMed PMID: 7546397).
11. Korzus E., Nagase H., Rydell R., Travis J. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J. Biol. Chem. 1997, 272(2):1188-1196. (PubMed PMID: 8995420).
12. Long K., Abuelenen T., Pava L., Bastille M., Blanck G. Size matters: sequential mutations in tumorigenesis may reflect the stochastic effect of mutagen target sizes. Genes Cancer 2011, 2(10):927-931. (PubMed PMID: 22701759; PubMed Central PMCID: PMC3374629). 10.1177/1947601911436200.
13. Luo Y., Liang F., Zhang Z.Y. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. Biochemistry 2009, 48(8):1838-1846. (PubMed PMID: 19199380; PubMed Central PMCID: PMC2765538). 10.1021/bi8020789.
14. McCawley L.J., Li S., Wattenberg E.V., Hudson L.G. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 1999, 274(7):4347-4353. (PubMed PMID: 9933637).
15. McKay B.C., Stubbert L.J., Fowler C.C., Smith J.M., Cardamore R.A., Spronck J.C. Regulation of ultraviolet light-induced gene expression by gene size. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(17):6582-6586. (PubMed PMID: 15087501; PubMed Central PMCID: PMC404088). 10.1073/pnas.0308181101.
16. Montesano R., Soriano J.V., Hosseini G., Pepper M.S., Schramek H. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells. Cell Growth Differ. 1999, 10(5):317-332. (PubMed PMID: 10359013).
17. Oswald F., Dobner T., Lipp M. The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle. Mol. Cell. Biol. 1996, 16(5):1889-1895. (PubMed PMID: 8628255; PubMed Central PMCID: PMC231176).
18. Phillips A.C., Vousden K.H. E2F-1 induced apoptosis. Apoptosis 2001, 6(3):173-182. (PubMed PMID: 11388666).
19. Ridder D.A., Schwaninger M. NF-kappaB signaling in cerebral ischemia. Neuroscience 2009, 158(3):995-1006. (PubMed PMID: 18675321). 10.1016/j.neuroscience.2008.07.007.
20. Wiegers G.J., Kaufmann M., Tischner D., Villunger A. Shaping the T-cell repertoire: a matter of life and death. Immunol. Cell Biol. 2011, 89(1):33-39. (PubMed PMID: 21060321). 10.1038/icb.2010.127.
21. Yamasaki L., Jacks T., Bronson R., Goillot E., Harlow E., Dyson N.J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996, 85(4):537-548. (PubMed PMID: 8653789).